Cindy Eide

Dr. Cindy Eide

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2020 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
Mark OsbornMark Osborn
Mark Osborn
GNGregory Newby
Gregory Newby
AMAmber N. McElroy
Amber N. McElroy
FKFriederike Knipping
Friederike Knipping
SNSarah C. Nielsen
Sarah C. Nielsen
JTJakub Tolar
Jakub Tolar

9 April 2018 in PLOS Computational Biology
Verified
Journal Article
Open access
PDF file
HZHuanan Zhang
Huanan Zhang
CLCatherine A. A. Lee
Catherine A. A. Lee
ZLZhuliu Li
Zhuliu Li
JGJohn R. Garbe
John R. Garbe
CECindy Eide
Cindy Eide
JTJakub Tolar
Jakub Tolar
Single-cell RNA sequencing (scRNA-seq) has been widely applied to discover new cell types by detecting sub-populations in a heterogeneous group of cells. Since scRNA-seq experiments have lower read coverage/tag counts and introduce more technical biases compared to bulk RNA-seq experiments, the limited number of sampled cells combined with the experimental biases and other dataset specific variations presents a challenge to cross-dataset analysis and discovery of relevant biological variations across multiple cell populations. In this paper, we introduce a method of variance-driven multitask clustering of single-cell RNA-seq data (scVDMC) that utilizes multiple single-cell populations from biological replicates or different samples. scVDMC clusters single cells in multiple scRNA-seq experiments of similar cell types and markers but varying expression patterns such that the scRNA-seq data are better integrated than typical pooled analyses which only increase the sample size. By controlling the variance among the cell clusters within each dataset and across all the datasets, scVDMC detects cell sub-populations in each individual experiment with shared cell-type markers but varying cluster centers among all the experiments. Applied to two real scRNA-seq datasets with several replicates and one large-scale droplet-based dataset on three patient samples, scVDMC more accurately detected cell populations and known cell markers than pooled clustering and other recently proposed scRNA-seq clustering methods. In the case study applied to in-house Recessive Dystrophic Epidermolysis Bullosa (RDEB) scRNA-seq data, scVDMC revealed several new cell types and unknown markers validated by flow cytometry. MATLAB/Octave code available at https://github.com/kuanglab/scVDMC. scRNA-seq enables detailed profiling of heterogeneous cell populations and can be used to reveal lineage relationships or discover new cell types. In the literature, there has been little effort directed towards developing computational methods for cross-population transcriptome analysis of multiple single-cell populations. The cross-cell-population clustering problem is different from the traditional clustering problem because single-cell populations can be collected from different patients, different samples of a tissue, or different experimental replicates. The accompanying biological and technical variation tends to dominate the signals for clustering the pooled single cells from the multiple populations. In this work, we have developed a multitask clustering method to address the cross-population clustering problem. The method simultaneously clusters each individual cell population and controls variance among the cell-type cluster centers within each cell population and across the cell populations. We demonstrate that our multitask clustering method significantly improves clustering accuracy and marker discovery in three public scRNA-seq datasets and also apply the method to an in-house Recessive Dystrophic Epidermolysis Bullosa (RDEB) dataset. Our results make it evident that multitask clustering is a promising new approach for cross-population analysis of scRNA-seq data.

16 March 2023 in Blood
Verified
Journal Article
Closed access
PDF file
TRTeresa L. Ramos
Teresa L. Ramos
SBSara Bolivar-Wagers
Sara Bolivar-Wagers
SJSujeong Jin
Sujeong Jin
GTGovindarajan Thangavelu
Govindarajan Thangavelu
FSFederico Simonetta
Federico Simonetta
BBBruce R. Blazar
Bruce R. Blazar
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a curative option for patients with hematological disorders and bone marrow (BM) failure syndromes. Graft-versus-host disease (GVHD) remains a leading cause of morbidity posttransplant. Regulatory T cell (Treg) therapies are efficacious in ameliorating GVHD but limited by variable suppressive capacities and the need for a high therapeutic dose. Here, we sought to expand Treg in vivo by expressing an orthogonal interleukin 2 receptor β (oIL-2Rβ) that would selectively interact with oIL-2 cytokine and not wild-type (WT) IL-2. To test whether the orthogonal system would preferentially drive donor Treg expansion, we used a murine major histocompatibility complex–disparate GVHD model of lethally irradiated BALB/c mice given T cell–depleted BM from C57BL/6 (B6) mice alone or together with B6Foxp3+GFP+ Treg or oIL-2Rβ–transduced Treg at low cell numbers that typically do not control GVHD with WT Treg. On day 2, B6 activated T cells (Tcons) were injected to induce GVHD. Recipients were treated with phosphate-buffered saline (PBS) or oIL-2 daily for 14 days, then 3 times weekly for an additional 14 days. Mice treated with oIL-2Rβ Treg and oIL-2 compared with those treated with PBS had enhanced GVHD survival, in vivo selective expansion of Tregs, and greater suppression of Tcon expansion in secondary lymphoid organs and intestines. Importantly, oIL-2Rβ Treg maintained graft-versus-tumor (GVT) responses in 2 distinct tumor models (A20 and MLL-AF9). These data demonstrate a novel approach to enhance the efficacy of Treg therapy in allo-HSCT using an oIL-2/oIL-2Rβ system that allows for selective in vivo expansion of Treg leading to GVHD protection and GVT maintenance.

Verified
Journal Article
Open access
PDF file
Mark OsbornMark Osborn
Mark Osborn
CLChris J Lees
Chris J Lees
AMAmber N. McElroy
Amber N. McElroy
SMSarah C. Merkel
Sarah C. Merkel
CECindy Eide
Cindy Eide
JTJakub Tolar
Jakub Tolar
Gene and cellular therapies hold tremendous promise as agents for treating genetic disorders. However, the effective delivery of genes, particularly large ones, and expression at therapeutic levels can be challenging in cells of clinical relevance. To address this engineering hurdle, we sought to employ the clustered regularly interspaced short palindromic repeats (CRISPR)/Cas9 system to insert powerful regulatory elements upstream of an endogenous gene. We achieved robust activation of the COL7A1 gene in primary human umbilical cord blood CD34+ hematopoietic stem cells and peripheral blood T-cells. CD34+ cells retained their colony forming potential and, in a second engineering step, we disrupted the T-cell receptor complex in T-cells. These cellular populations are of high translational impact due to their engraftment potential, broad circulatory properties, and favorable immune profile that supports delivery to multiple recipients. This study demonstrates the feasibility of targeted knock in of a ubiquitous chromatin opening element, promoter, and marker gene that doubles as a suicide gene for precision gene activation. This system merges the specificity of gene editing with the high level, sustained gene expression achieved with gene therapy vectors. We predict that this design concept will be highly transferrable to most genes in multiple model systems representing a facile cellular engineering platform for promoting gene expression.

1 December 2019 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
AOAlexandros Onoufriadis
Alexandros Onoufriadis
CHChao-Kai Hsu
Chao-Kai Hsu
CECindy Eide
Cindy Eide
ANArti Nanda
Arti Nanda
GOGuy E. Orchard
Guy E. Orchard
JMJohn A. McGrath
John A. McGrath

12 April 2024 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
CPCourtney Popp
Courtney Popp
WMWilliam Miller
William Miller
CECindy Eide
Cindy Eide
JTJakub Tolar
Jakub Tolar
JMJohn A. McGrath
John A. McGrath
CEChristen L. Ebens
Christen L. Ebens